Evo Fund raises stake in Modalis Therapeutics to 6.54%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-08-20 10:27 JST concerning Modalis Therapeutics Corporation. Reported holding ratio: 6.54%, previous report: 6.26%.